KORU Medical Systems, Inc. (NASDAQ:KRMD) Shares Sold by 272 Capital LP

272 Capital LP trimmed its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 58.5% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 308,280 shares of the company’s stock after selling 434,793 shares during the period. 272 Capital LP owned approximately 0.67% of KORU Medical Systems worth $817,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of KRMD. First Light Asset Management LLC lifted its stake in KORU Medical Systems by 1.1% during the 1st quarter. First Light Asset Management LLC now owns 5,220,990 shares of the company’s stock worth $12,322,000 after acquiring an additional 57,253 shares in the last quarter. Archon Capital Management LLC increased its stake in KORU Medical Systems by 6.2% during the first quarter. Archon Capital Management LLC now owns 3,951,393 shares of the company’s stock worth $9,325,000 after purchasing an additional 230,517 shares during the period. Vanguard Group Inc. increased its stake in KORU Medical Systems by 2.7% during the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock worth $4,630,000 after purchasing an additional 51,890 shares during the period. Lakewood Asset Management LLC lifted its position in shares of KORU Medical Systems by 13.9% during the second quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock worth $181,000 after purchasing an additional 8,300 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of KORU Medical Systems in the first quarter valued at approximately $63,000. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

KRMD has been the subject of several research reports. Piper Sandler boosted their price target on shares of KORU Medical Systems from $2.50 to $3.00 and gave the stock an “overweight” rating in a research note on Thursday, August 8th. B. Riley initiated coverage on KORU Medical Systems in a research note on Thursday, July 25th. They set a “buy” rating and a $4.00 target price for the company.

KORU Medical Systems Trading Down 0.4 %

KRMD opened at $2.68 on Tuesday. The company has a quick ratio of 3.27, a current ratio of 3.77 and a debt-to-equity ratio of 0.01. KORU Medical Systems, Inc. has a 52 week low of $1.98 and a 52 week high of $3.09. The business’s 50 day moving average is $2.44 and its two-hundred day moving average is $2.34. The firm has a market cap of $122.65 million, a price-to-earnings ratio of -9.57 and a beta of 0.42.

KORU Medical Systems (NASDAQ:KRMD) last released its quarterly earnings results on Wednesday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 20.82% and a negative net margin of 38.16%. The firm had revenue of $8.43 million for the quarter, compared to analyst estimates of $7.52 million. During the same quarter last year, the company posted ($0.05) earnings per share. On average, research analysts predict that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.